Covid-19 Oral Medicine -- a Link to be focused on Against Epidemic
In the wake of the outbreak of the COVID-19, the globally cumulative infected population has capped 100 million, which poses a huge impact on human activities.
July 26, 2021
by PharmaSources/Chuxin
Phase I trial of mRNA-based influenza vaccine begins
The trial will assess a monovalent mRNA-based vaccine candidate against seasonal influenza caused by the A/H3N2 strain.
June 24, 2021
by europeanpharmaceuticalreview
Influenza Vaccine and Novavax COVID-19 Vaccine Simultaneous Administration Yields Positive Results
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax, NVX-CoV2373] and an approved influenza vaccine ...
June 17, 2021
by americanpharmaceuticalreview
What strains should be in this year’s seasonal influenza vaccines?
The European Medicines Agency has published its recommendations for 2021-2022 seasonal influenza vaccine composition.
March 31, 2021
by europeanpharmaceuticalreview
Intravacc and Versatope to develop universal influenza vaccine based on OMV technology
According to Centers for Disease Control and Prevention, influenza vaccines were overall 29 per cent effective during the 2018–2019 influenza season due to the emergence of new, late season viral strains.
June 9, 2020
by expresspharma
Emergent Signs Manufacturing Agreement with Novavax
Emergent BioSolutions has entered an agreement with Novavax to provide molecule-to-market contract development and manufacturing services to produce Novavax’s NanoFlu.
April 6, 2020
by contractpharma
A Next Generation Sequencing (NGS) Approach to Influenza Vaccine Development
Influenza is a seasonal disease. It fluctuates in a very typical manner, and probably has for centuries, but certainly for decades since it’s been monitored.
August 25, 2019
by fiercepharma
FDA Approves Use of Fluzone Quadrivalent in Children as Young as 6 Months
The U.S. Food and Drug Administration (FDA) has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6 months through 35 months....
January 25, 2019
by americanpharmaceuticalreview
Anti-vaccine sentiment causing deaths, subjecting women to cervical cancer, expert says
In recent years, the anti-vaccine movement has gained steam and attracted a growing number of headlines. Now, a vaccine expert says the movement is starting to result in its first deaths.
December 6, 2018
by fiercepharma
BiondVax relocates to new manufacturing facility
BiondVax Pharmaceuticals Ltd. recently reported the company's relocation to a newly constructed mid-size commercial scale manufacturing facility in Jerusalem, Israel.
August 21, 2018
by biospectrumasia
Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine (QIV) candidate.
September 27, 2017
by americanpharmaceuticacreview
Hong Kong, S.A.R., China doctor found giving expired flu vaccines to patients
A doctor in Hong Kong, S.A.R., China Special Administrative Region of China was found giving expired flu vaccines to patients.
August 23, 2017
by fiercepharma